Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced that Abdul Hamid Halabi has joined as Senior Vice President of Data Products. Abdul has been a pioneer in AI and healthcare, developing key concepts in AI-powered diagnostics and intelligent medical devices and will leverage his expertise and skills in building LENS, Tempus’ data and AI precision medicine platform.
Abdul comes from NVIDIA, a technology leader in AI, where he led the healthcare team in driving business growth and innovation into medicine and medical devices. He has been at the forefront of advanced technologies in AI for several decades, working with top global thought leaders and world-class organizations to bring AI to patient care. Abdul launched NVIDIA’s Health platform, Clara, to reach thousands of developers and deployment sites.
“Tempus is a leader in bringing the power of AI to diagnostics and precision medicine, empowering physicians to make real-time, data-driven decisions and enabling life science companies to efficiently develop targeted therapeutics,” said Ryan Fukushima, Chief Operating Officer of Tempus. “Abdul brings expertise to expand our partnerships, leveraging multi-modal datasets to power the practical applications of AI to improve patient care.”
“AI has proven to be a game changer in healthcare, analyzing large amounts of unstructured data and extracting key insights hardly accessible before,” said Abdul Hamid Halabi. “Tempus has the unique combination of useful multi-modal data, world-class data science teams and established clinical relationships to build and bring AI to patient care. I couldn’t be more excited to join the team.”
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit www.tempus.com